Embolotherapy Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Embolotherapy market size was valued at USD 3918 million in 2022 and is forecast to a readjusted size of USD 6168.7 million by 2029 with a CAGR of 6.7% during review period.

This report is a detailed and comprehensive analysis for global Embolotherapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Global key players of Embolotherapy include Medtronic, Boston Scientific, etc. Global top 3 companies hold a share over 30%. North America is the largest market, with a share about 35%, followed by Europe and China with the share about 25% and 20%. In terms of product, Microspheres for Embolization is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer, with a share about 50%.

Key Features:

Global Embolotherapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Embolotherapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Embolotherapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Embolotherapy market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Embolotherapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Embolotherapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Medtronic
   Boston Scientific
   Terumo
   Penumbra, Inc.
   Johnson & Johnson
   Sirtex
   Merit Medical
   Varian
   Stryker
   Jiangsu Hengrui Pharmaceuticals Co., Ltd
   Cook Medical
   Kaneka
   Meril Life Sciences
   Peijia Medical Limited
   Wallaby Medical
   MicroPort Scientific Corporation
   Shandong Visee Medical Devices Co.,Ltd
   Beijing Taijie Weiye Technology

   Microspheres for Embolization
   Embolism Particles
   Embolic coils
   Liquid Embolic Agent
   Auxiliary Embolization Material
   Others

   Cancer
   Peripheral Aascular Disease
   Nerve System Disease
   Others

   North America (United States, Canada, and Mexico)
   Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
   South America (Brazil, Argentina and Rest of South America)
   Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

What are the strengths of the embolotherapy market in 2025?

The embolotherapy market benefits from growing demand for minimally invasive procedures, increasing adoption of advanced medical devices, and improving patient outcomes. With rising cases of cancers, aneurysms, and other vascular diseases, the market is poised for growth. Additionally, continuous technological advancements in embolization materials and equipment are further strengthening the market.

What are the weaknesses of the embolotherapy market in 2025?

The main weaknesses include the high cost of embolotherapy procedures, which can limit accessibility for some patients. Additionally, there may be concerns regarding the availability of trained professionals and the potential for complications, such as ischemia or embolism, which could hinder the market’s broader adoption.

What are the opportunities for the embolotherapy market in 2025?

There are significant opportunities in expanding into emerging markets where healthcare infrastructure is improving. With the rising prevalence of chronic diseases and an aging population, there is a growing need for effective treatment options like embolotherapy. Furthermore, innovation in bioresorbable embolization agents and personalized treatments could open up new markets.

What are the threats to the embolotherapy market in 2025?

The embolotherapy market faces threats from regulatory challenges, particularly in the approval of new products, which could slow down market growth. Additionally, competition from alternative treatment options, such as surgery or radiotherapy, and potential reimbursement issues could limit market expansion. Economic fluctuations and healthcare spending cuts could also impact the market’s growth.

What are the political factors affecting the embolotherapy market in 2025?

Political factors include government regulations and policies related to healthcare reimbursement, as well as the approval processes for medical devices and treatments. Changes in healthcare policies, particularly in countries with public healthcare systems, could impact the adoption and affordability of embolotherapy treatments.

How do economic factors influence the embolotherapy market in 2025?

Economic factors like healthcare budgets, income levels, and the economic stability of regions directly affect the affordability and availability of embolotherapy. In times of economic downturn, reduced spending on healthcare services could limit patient access to advanced treatments, including embolotherapy.

What are the social factors impacting the embolotherapy market in 2025?

Social factors include the increasing awareness of minimally invasive procedures among patients and healthcare providers. As people become more informed about treatment options, there is a growing demand for effective and less invasive solutions. Additionally, an aging population and rising prevalence of chronic diseases increase the need for embolotherapy treatments.

What technological factors are shaping the embolotherapy market in 2025?

Technological advancements, such as improved embolization materials, imaging technologies, and robotics, are enhancing the precision and effectiveness of embolotherapy. Innovations in treatment options and the development of personalized therapies will continue to shape the market, offering more tailored solutions for patients.

What environmental factors could impact the embolotherapy market in 2025?

Environmental factors include the increasing focus on sustainability within the healthcare sector, including the production and disposal of medical devices and materials. There may be rising pressure on manufacturers to adopt eco-friendly practices in the production of embolotherapy devices, as well as adhere to stricter environmental regulations.

What legal factors affect the embolotherapy market in 2025?

Legal factors encompass regulatory requirements for product approvals, patents, and clinical trials. Intellectual property rights, along with evolving legal frameworks for medical device approval and patient safety, could impact market entry for new companies or innovations in embolotherapy. Additionally, legal challenges regarding malpractice or complications from treatments could influence market growth.

Who are the suppliers in the embolotherapy market in 2025?

Suppliers include manufacturers of embolization devices, such as embolic particles, coils, and catheters, as well as producers of imaging equipment used in embolotherapy procedures. Pharmaceutical companies providing contrast agents or other adjunctive therapies are also key suppliers.

Who are the inputs for the embolotherapy market in 2025?

The primary inputs are advanced medical devices and materials, such as embolic agents, delivery systems, and imaging technologies. Additionally, skilled healthcare professionals and clinical expertise in performing embolotherapy are essential inputs for the market.

What are the processes in the embolotherapy market in 2025?

Processes include research and development of new embolization technologies, production of embolic devices, regulatory approval and certification, and the training of healthcare professionals. Clinical procedures involve diagnosis, patient selection, and performing embolization treatments in hospitals or specialized clinics.

Who are the customers in the embolotherapy market in 2025?

Customers include hospitals, clinics, and healthcare providers offering minimally invasive treatments to patients with vascular diseases, tumors, or other conditions requiring embolotherapy. Patients themselves are indirect customers, as they seek effective and less invasive treatment options for their medical conditions.

What are the outputs of the embolotherapy market in 2025?

The outputs are the embolization devices and treatments provided to healthcare providers, along with improved patient outcomes such as reduced tumor sizes, controlled bleeding, and effective management of aneurysms. Additionally, continuous advancements in treatment methods and patient care contribute to the market's overall growth.

What is the threat of new entrants in the embolotherapy market in 2025?

The threat of new entrants is moderate. While there is room for innovation and growth, high barriers to entry exist due to the significant capital investment needed for research, development, and regulatory approval of medical devices. Additionally, established players have strong brand recognition and distribution networks, making it difficult for new companies to enter.

What is the bargaining power of suppliers in the embolotherapy market in 2025?

The bargaining power of suppliers is moderate. While there are a limited number of specialized suppliers for embolic materials and devices, the increasing number of manufacturers and the demand for advanced technologies help balance their power. However, suppliers with unique, high-demand products can exert greater influence over pricing.

What is the bargaining power of buyers in the embolotherapy market in 2025?

The bargaining power of buyers is low to moderate. Healthcare providers, including hospitals and clinics, have some negotiating power, especially when purchasing in bulk or choosing from multiple suppliers. However, since embolotherapy is a specialized, high-cost treatment, most patients have limited bargaining power, relying on healthcare providers to make treatment decisions.

What is the threat of substitute products or services in the embolotherapy market in 2025?

The threat of substitutes is moderate. While embolotherapy is a preferred minimally invasive treatment option, alternatives like surgical procedures, radiotherapy, or systemic chemotherapy may compete in specific cases. However, embolotherapy offers distinct advantages in terms of reduced recovery time and fewer complications, which limits the threat of substitutes.

What is the intensity of competitive rivalry in the embolotherapy market in 2025?

The intensity of competitive rivalry is high. The embolotherapy market has a number of established players, including major medical device manufacturers, creating a competitive environment. Companies are investing heavily in R&D and new technologies to differentiate their products, leading to constant innovation and competitive pressure to maintain market share.

What are the key raw materials and components required for the embolotherapy market in 2025?

The key raw materials include biocompatible polymers, metals for coils, and embolic particles made from materials like gelatin, polyvinyl alcohol, and calcium carbonate. Additionally, contrast agents, imaging devices, and delivery systems such as catheters are essential components for performing embolotherapy procedures.

Who are the key suppliers in the upstream segment of the embolotherapy market in 2025?

Key suppliers include manufacturers of medical-grade materials, such as suppliers of polymers and metals used in embolic devices. Companies that produce imaging equipment and contrast agents, as well as those providing advanced delivery systems and tools, also play an important role in the upstream supply chain.

What is the role of research and development in the upstream segment of the embolotherapy market in 2025?

Research and development (R&D) are crucial in the upstream segment, as companies focus on creating more effective and innovative embolic materials, improving the safety and precision of delivery systems, and advancing imaging technologies. R&D helps meet the growing demand for better, less invasive treatments and drives the evolution of embolotherapy procedures.

How does regulatory compliance affect the upstream segment of the embolotherapy market in 2025?

Regulatory compliance plays a significant role in the upstream segment, as manufacturers must ensure their materials, devices, and products meet stringent safety and efficacy standards set by regulatory bodies like the FDA and EMA. These regulations can impact the time to market and influence suppliers' decisions to innovate within approved frameworks.

What are the challenges faced by suppliers in the upstream embolotherapy market in 2025?

Suppliers face challenges such as the high cost of research and development, the need for continuous innovation to meet market demands, and the complexity of regulatory approvals. Additionally, ensuring the availability of high-quality raw materials that meet medical standards while keeping costs manageable can be challenging in the upstream supply chain.

What are the key players in the midstream segment of the embolotherapy market in 2025?

Key players in the midstream segment include distributors and wholesalers who play a crucial role in the supply chain, ensuring that embolotherapy devices, materials, and equipment are delivered to hospitals, clinics, and healthcare providers. These players also include medical device companies that design, manufacture, and distribute embolization products.

How does the distribution network impact the embolotherapy market in 2025?

The distribution network is vital for the embolotherapy market, as it ensures that specialized devices and materials reach healthcare providers in a timely and efficient manner. A robust distribution system helps maintain product availability and facilitates quick access to advanced treatments, which is essential for the success of embolotherapy procedures.

What is the role of healthcare providers in the midstream segment of the embolotherapy market in 2025?

Healthcare providers, including hospitals, clinics, and specialized treatment centers, are essential in the midstream segment. They utilize embolotherapy devices to perform minimally invasive treatments, such as tumor embolization and vascular embolization, directly impacting patient care and treatment outcomes. Their adoption and use of the latest technologies influence market growth and demand.

What are the logistical challenges in the midstream embolotherapy market in 2025?

Logistical challenges include the need for temperature-sensitive transportation of certain embolotherapy materials, as well as the complexity of maintaining an uninterrupted supply of specialized products. Geographic disparities in healthcare infrastructure can also cause delays in product delivery, especially in emerging markets where access to advanced treatments may be limited.

How do partnerships and collaborations impact the midstream segment in the embolotherapy market in 2025?

Partnerships and collaborations between medical device manufacturers, distributors, and healthcare providers are key to expanding the reach of embolotherapy treatments. These alliances can improve market penetration, facilitate better training for healthcare professionals, and ensure access to the latest devices and technologies, ultimately enhancing the quality of patient care.

What are the key end-users in the downstream segment of the embolotherapy market in 2025?

Key end-users in the downstream segment include hospitals, specialized clinics, and outpatient centers that perform embolotherapy procedures. Additionally, physicians, interventional radiologists, and oncologists who specialize in vascular and cancer treatments play an important role in the adoption and execution of these procedures.

How does patient demand influence the downstream segment of the embolotherapy market in 2025?

Patient demand is growing as more people seek minimally invasive treatment options for conditions like tumors, aneurysms, and chronic bleeding. As patients become more aware of the benefits of embolotherapy, such as shorter recovery times and fewer complications, their preferences directly influence healthcare providers to adopt and offer these treatments.

What impact do healthcare policies have on the downstream embolotherapy market in 2025?

Healthcare policies, particularly those related to insurance coverage and reimbursement rates, significantly affect the downstream market. Policies that support the coverage of embolotherapy procedures ensure broader access to these treatments, driving their adoption among healthcare providers and patients, while restrictive policies could limit their availability.

What are the challenges faced by healthcare providers in the downstream segment of the embolotherapy market in 2025?

Healthcare providers face challenges such as the high costs of embolotherapy treatments, limited reimbursement from insurance companies, and the need for continuous training to stay updated on the latest techniques and technologies. Additionally, patient selection criteria and the complexity of some embolization procedures may also pose challenges in achieving optimal outcomes.

How do technological advancements impact the downstream segment in the embolotherapy market in 2025?

Technological advancements such as improved imaging techniques, better embolic materials, and more precise delivery systems enhance the effectiveness and safety of embolotherapy. These innovations improve the quality of care, lead to better patient outcomes, and drive the adoption of embolotherapy in both developed and emerging markets.

Chapter 1, to describe Embolotherapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Embolotherapy, with revenue, gross margin and global market share of Embolotherapy from 2018 to 2023.
Chapter 3, the Embolotherapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Embolotherapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Embolotherapy.
Chapter 13, to describe Embolotherapy research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Embolotherapy
   1.2 Market Estimation Caveats and Base Year
   1.3 Classification of Embolotherapy by Type
       1.3.1 Overview: Global Embolotherapy Market Size by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Global Embolotherapy Consumption Value Market Share by Type in 2022
       1.3.3 Microspheres for Embolization
       1.3.4 Embolism Particles
       1.3.5 Embolic coils
       1.3.6 Liquid Embolic Agent
       1.3.7 Auxiliary Embolization Material
       1.3.8 Others
   1.4 Global Embolotherapy Market by Application
       1.4.1 Overview: Global Embolotherapy Market Size by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Cancer
       1.4.3 Peripheral Aascular Disease
       1.4.4 Nerve System Disease
       1.4.5 Others
   1.5 Global Embolotherapy Market Size & Forecast
   1.6 Global Embolotherapy Market Size and Forecast by Region
       1.6.1 Global Embolotherapy Market Size by Region: 2018 VS 2022 VS 2029
       1.6.2 Global Embolotherapy Market Size by Region, (2018-2029)
       1.6.3 North America Embolotherapy Market Size and Prospect (2018-2029)
       1.6.4 Europe Embolotherapy Market Size and Prospect (2018-2029)
       1.6.5 Asia-Pacific Embolotherapy Market Size and Prospect (2018-2029)
       1.6.6 South America Embolotherapy Market Size and Prospect (2018-2029)
       1.6.7 Middle East and Africa Embolotherapy Market Size and Prospect (2018-2029)

2 Company Profiles

   2.1 Medtronic
       2.1.1 Medtronic Details
       2.1.2 Medtronic Major Business
       2.1.3 Medtronic Embolotherapy Product and Solutions
       2.1.4 Medtronic Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Medtronic Recent Developments and Future Plans
   2.2 Boston Scientific
       2.2.1 Boston Scientific Details
       2.2.2 Boston Scientific Major Business
       2.2.3 Boston Scientific Embolotherapy Product and Solutions
       2.2.4 Boston Scientific Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Boston Scientific Recent Developments and Future Plans
   2.3 Terumo
       2.3.1 Terumo Details
       2.3.2 Terumo Major Business
       2.3.3 Terumo Embolotherapy Product and Solutions
       2.3.4 Terumo Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Terumo Recent Developments and Future Plans
   2.4 Penumbra, Inc.
       2.4.1 Penumbra, Inc. Details
       2.4.2 Penumbra, Inc. Major Business
       2.4.3 Penumbra, Inc. Embolotherapy Product and Solutions
       2.4.4 Penumbra, Inc. Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Penumbra, Inc. Recent Developments and Future Plans
   2.5 Johnson & Johnson
       2.5.1 Johnson & Johnson Details
       2.5.2 Johnson & Johnson Major Business
       2.5.3 Johnson & Johnson Embolotherapy Product and Solutions
       2.5.4 Johnson & Johnson Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Johnson & Johnson Recent Developments and Future Plans
   2.6 Sirtex
       2.6.1 Sirtex Details
       2.6.2 Sirtex Major Business
       2.6.3 Sirtex Embolotherapy Product and Solutions
       2.6.4 Sirtex Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Sirtex Recent Developments and Future Plans
   2.7 Merit Medical
       2.7.1 Merit Medical Details
       2.7.2 Merit Medical Major Business
       2.7.3 Merit Medical Embolotherapy Product and Solutions
       2.7.4 Merit Medical Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Merit Medical Recent Developments and Future Plans
   2.8 Varian
       2.8.1 Varian Details
       2.8.2 Varian Major Business
       2.8.3 Varian Embolotherapy Product and Solutions
       2.8.4 Varian Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Varian Recent Developments and Future Plans
   2.9 Stryker
       2.9.1 Stryker Details
       2.9.2 Stryker Major Business
       2.9.3 Stryker Embolotherapy Product and Solutions
       2.9.4 Stryker Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Stryker Recent Developments and Future Plans
   2.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd 
       2.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Details
       2.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
       2.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product and Solutions
       2.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments and Future Plans
   2.11 Cook Medical
       2.11.1 Cook Medical Details
       2.11.2 Cook Medical Major Business
       2.11.3 Cook Medical Embolotherapy Product and Solutions
       2.11.4 Cook Medical Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Cook Medical Recent Developments and Future Plans
   2.12 Kaneka
       2.12.1 Kaneka Details
       2.12.2 Kaneka Major Business
       2.12.3 Kaneka Embolotherapy Product and Solutions
       2.12.4 Kaneka Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Kaneka Recent Developments and Future Plans
   2.13 Meril Life Sciences
       2.13.1 Meril Life Sciences Details
       2.13.2 Meril Life Sciences Major Business
       2.13.3 Meril Life Sciences Embolotherapy Product and Solutions
       2.13.4 Meril Life Sciences Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.13.5 Meril Life Sciences Recent Developments and Future Plans
   2.14 Peijia Medical Limited
       2.14.1 Peijia Medical Limited Details
       2.14.2 Peijia Medical Limited Major Business
       2.14.3 Peijia Medical Limited Embolotherapy Product and Solutions
       2.14.4 Peijia Medical Limited Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.14.5 Peijia Medical Limited Recent Developments and Future Plans
   2.15 Wallaby Medical
       2.15.1 Wallaby Medical Details
       2.15.2 Wallaby Medical Major Business
       2.15.3 Wallaby Medical Embolotherapy Product and Solutions
       2.15.4 Wallaby Medical Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.15.5 Wallaby Medical Recent Developments and Future Plans
   2.16 MicroPort Scientific Corporation
       2.16.1 MicroPort Scientific Corporation Details
       2.16.2 MicroPort Scientific Corporation Major Business
       2.16.3 MicroPort Scientific Corporation Embolotherapy Product and Solutions
       2.16.4 MicroPort Scientific Corporation Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.16.5 MicroPort Scientific Corporation Recent Developments and Future Plans
   2.17 Shandong Visee Medical Devices Co.,Ltd
       2.17.1 Shandong Visee Medical Devices Co.,Ltd Details
       2.17.2 Shandong Visee Medical Devices Co.,Ltd Major Business
       2.17.3 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Product and Solutions
       2.17.4 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.17.5 Shandong Visee Medical Devices Co.,Ltd Recent Developments and Future Plans
   2.18 Beijing Taijie Weiye Technology
       2.18.1 Beijing Taijie Weiye Technology Details
       2.18.2 Beijing Taijie Weiye Technology Major Business
       2.18.3 Beijing Taijie Weiye Technology Embolotherapy Product and Solutions
       2.18.4 Beijing Taijie Weiye Technology Embolotherapy Revenue, Gross Margin and Market Share (2018-2023)
       2.18.5 Beijing Taijie Weiye Technology Recent Developments and Future Plans

3 Market Competition, by Players

   3.1 Global Embolotherapy Revenue and Share by Players (2018-2023)
   3.2 Market Share Analysis (2022)
       3.2.1 Market Share of Embolotherapy by Company Revenue
       3.2.2 Top 3 Embolotherapy Players Market Share in 2022
       3.2.3 Top 6 Embolotherapy Players Market Share in 2022
   3.3 Embolotherapy Market: Overall Company Footprint Analysis
       3.3.1 Embolotherapy Market: Region Footprint
       3.3.2 Embolotherapy Market: Company Product Type Footprint
       3.3.3 Embolotherapy Market: Company Product Application Footprint
   3.4 New Market Entrants and Barriers to Market Entry
   3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

   4.1 Global Embolotherapy Consumption Value and Market Share by Type (2018-2023)
   4.2 Global Embolotherapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

   5.1 Global Embolotherapy Consumption Value Market Share by Application (2018-2023)
   5.2 Global Embolotherapy Market Forecast by Application (2024-2029)

6 North America

   6.1 North America Embolotherapy Consumption Value by Type (2018-2029)
   6.2 North America Embolotherapy Consumption Value by Application (2018-2029)
   6.3 North America Embolotherapy Market Size by Country
       6.3.1 North America Embolotherapy Consumption Value by Country (2018-2029)
       6.3.2 United States Embolotherapy Market Size and Forecast (2018-2029)
       6.3.3 Canada Embolotherapy Market Size and Forecast (2018-2029)
       6.3.4 Mexico Embolotherapy Market Size and Forecast (2018-2029)

7 Europe

   7.1 Europe Embolotherapy Consumption Value by Type (2018-2029)
   7.2 Europe Embolotherapy Consumption Value by Application (2018-2029)
   7.3 Europe Embolotherapy Market Size by Country
       7.3.1 Europe Embolotherapy Consumption Value by Country (2018-2029)
       7.3.2 Germany Embolotherapy Market Size and Forecast (2018-2029)
       7.3.3 France Embolotherapy Market Size and Forecast (2018-2029)
       7.3.4 United Kingdom Embolotherapy Market Size and Forecast (2018-2029)
       7.3.5 Russia Embolotherapy Market Size and Forecast (2018-2029)
       7.3.6 Italy Embolotherapy Market Size and Forecast (2018-2029)

8 Asia-Pacific

   8.1 Asia-Pacific Embolotherapy Consumption Value by Type (2018-2029)
   8.2 Asia-Pacific Embolotherapy Consumption Value by Application (2018-2029)
   8.3 Asia-Pacific Embolotherapy Market Size by Region
       8.3.1 Asia-Pacific Embolotherapy Consumption Value by Region (2018-2029)
       8.3.2 China Embolotherapy Market Size and Forecast (2018-2029)
       8.3.3 Japan Embolotherapy Market Size and Forecast (2018-2029)
       8.3.4 South Korea Embolotherapy Market Size and Forecast (2018-2029)
       8.3.5 India Embolotherapy Market Size and Forecast (2018-2029)
       8.3.6 Southeast Asia Embolotherapy Market Size and Forecast (2018-2029)
       8.3.7 Australia Embolotherapy Market Size and Forecast (2018-2029)

9 South America

   9.1 South America Embolotherapy Consumption Value by Type (2018-2029)
   9.2 South America Embolotherapy Consumption Value by Application (2018-2029)
   9.3 South America Embolotherapy Market Size by Country
       9.3.1 South America Embolotherapy Consumption Value by Country (2018-2029)
       9.3.2 Brazil Embolotherapy Market Size and Forecast (2018-2029)
       9.3.3 Argentina Embolotherapy Market Size and Forecast (2018-2029)

10 Middle East & Africa

   10.1 Middle East & Africa Embolotherapy Consumption Value by Type (2018-2029)
   10.2 Middle East & Africa Embolotherapy Consumption Value by Application (2018-2029)
   10.3 Middle East & Africa Embolotherapy Market Size by Country
       10.3.1 Middle East & Africa Embolotherapy Consumption Value by Country (2018-2029)
       10.3.2 Turkey Embolotherapy Market Size and Forecast (2018-2029)
       10.3.3 Saudi Arabia Embolotherapy Market Size and Forecast (2018-2029)
       10.3.4 UAE Embolotherapy Market Size and Forecast (2018-2029)

11 Market Dynamics

   11.1 Embolotherapy Market Drivers
   11.2 Embolotherapy Market Restraints
   11.3 Embolotherapy Trends Analysis
   11.4 Porters Five Forces Analysis
       11.4.1 Threat of New Entrants
       11.4.2 Bargaining Power of Suppliers
       11.4.3 Bargaining Power of Buyers
       11.4.4 Threat of Substitutes
       11.4.5 Competitive Rivalry
   11.5 Influence of COVID-19 and Russia-Ukraine War
       11.5.1 Influence of COVID-19
       11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

   12.1 Embolotherapy Industry Chain
   12.2 Embolotherapy Upstream Analysis
   12.3 Embolotherapy Midstream Analysis
   12.4 Embolotherapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

   14.1 Methodology
   14.2 Research Process and Data Source
   14.3 Disclaimer

List of Tables

   Table 1. Global Embolotherapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Embolotherapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Global Embolotherapy Consumption Value by Region (2018-2023) & (USD Million)
   Table 4. Global Embolotherapy Consumption Value by Region (2024-2029) & (USD Million)
   Table 5. Medtronic Company Information, Head Office, and Major Competitors
   Table 6. Medtronic Major Business
   Table 7. Medtronic Embolotherapy Product and Solutions
   Table 8. Medtronic Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 9. Medtronic Recent Developments and Future Plans
   Table 10. Boston Scientific Company Information, Head Office, and Major Competitors
   Table 11. Boston Scientific Major Business
   Table 12. Boston Scientific Embolotherapy Product and Solutions
   Table 13. Boston Scientific Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 14. Boston Scientific Recent Developments and Future Plans
   Table 15. Terumo Company Information, Head Office, and Major Competitors
   Table 16. Terumo Major Business
   Table 17. Terumo Embolotherapy Product and Solutions
   Table 18. Terumo Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 19. Terumo Recent Developments and Future Plans
   Table 20. Penumbra, Inc. Company Information, Head Office, and Major Competitors
   Table 21. Penumbra, Inc. Major Business
   Table 22. Penumbra, Inc. Embolotherapy Product and Solutions
   Table 23. Penumbra, Inc. Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 24. Penumbra, Inc. Recent Developments and Future Plans
   Table 25. Johnson & Johnson Company Information, Head Office, and Major Competitors
   Table 26. Johnson & Johnson Major Business
   Table 27. Johnson & Johnson Embolotherapy Product and Solutions
   Table 28. Johnson & Johnson Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 29. Johnson & Johnson Recent Developments and Future Plans
   Table 30. Sirtex Company Information, Head Office, and Major Competitors
   Table 31. Sirtex Major Business
   Table 32. Sirtex Embolotherapy Product and Solutions
   Table 33. Sirtex Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 34. Sirtex Recent Developments and Future Plans
   Table 35. Merit Medical Company Information, Head Office, and Major Competitors
   Table 36. Merit Medical Major Business
   Table 37. Merit Medical Embolotherapy Product and Solutions
   Table 38. Merit Medical Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 39. Merit Medical Recent Developments and Future Plans
   Table 40. Varian Company Information, Head Office, and Major Competitors
   Table 41. Varian Major Business
   Table 42. Varian Embolotherapy Product and Solutions
   Table 43. Varian Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 44. Varian Recent Developments and Future Plans
   Table 45. Stryker Company Information, Head Office, and Major Competitors
   Table 46. Stryker Major Business
   Table 47. Stryker Embolotherapy Product and Solutions
   Table 48. Stryker Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 49. Stryker Recent Developments and Future Plans
   Table 50. Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Information, Head Office, and Major Competitors
   Table 51. Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
   Table 52. Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product and Solutions
   Table 53. Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 54. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments and Future Plans
   Table 55. Cook Medical Company Information, Head Office, and Major Competitors
   Table 56. Cook Medical Major Business
   Table 57. Cook Medical Embolotherapy Product and Solutions
   Table 58. Cook Medical Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 59. Cook Medical Recent Developments and Future Plans
   Table 60. Kaneka Company Information, Head Office, and Major Competitors
   Table 61. Kaneka Major Business
   Table 62. Kaneka Embolotherapy Product and Solutions
   Table 63. Kaneka Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 64. Kaneka Recent Developments and Future Plans
   Table 65. Meril Life Sciences Company Information, Head Office, and Major Competitors
   Table 66. Meril Life Sciences Major Business
   Table 67. Meril Life Sciences Embolotherapy Product and Solutions
   Table 68. Meril Life Sciences Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 69. Meril Life Sciences Recent Developments and Future Plans
   Table 70. Peijia Medical Limited Company Information, Head Office, and Major Competitors
   Table 71. Peijia Medical Limited Major Business
   Table 72. Peijia Medical Limited Embolotherapy Product and Solutions
   Table 73. Peijia Medical Limited Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 74. Peijia Medical Limited Recent Developments and Future Plans
   Table 75. Wallaby Medical Company Information, Head Office, and Major Competitors
   Table 76. Wallaby Medical Major Business
   Table 77. Wallaby Medical Embolotherapy Product and Solutions
   Table 78. Wallaby Medical Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 79. Wallaby Medical Recent Developments and Future Plans
   Table 80. MicroPort Scientific Corporation Company Information, Head Office, and Major Competitors
   Table 81. MicroPort Scientific Corporation Major Business
   Table 82. MicroPort Scientific Corporation Embolotherapy Product and Solutions
   Table 83. MicroPort Scientific Corporation Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 84. MicroPort Scientific Corporation Recent Developments and Future Plans
   Table 85. Shandong Visee Medical Devices Co.,Ltd Company Information, Head Office, and Major Competitors
   Table 86. Shandong Visee Medical Devices Co.,Ltd Major Business
   Table 87. Shandong Visee Medical Devices Co.,Ltd Embolotherapy Product and Solutions
   Table 88. Shandong Visee Medical Devices Co.,Ltd Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 89. Shandong Visee Medical Devices Co.,Ltd Recent Developments and Future Plans
   Table 90. Beijing Taijie Weiye Technology Company Information, Head Office, and Major Competitors
   Table 91. Beijing Taijie Weiye Technology Major Business
   Table 92. Beijing Taijie Weiye Technology Embolotherapy Product and Solutions
   Table 93. Beijing Taijie Weiye Technology Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 94. Beijing Taijie Weiye Technology Recent Developments and Future Plans
   Table 95. Global Embolotherapy Revenue (USD Million) by Players (2018-2023)
   Table 96. Global Embolotherapy Revenue Share by Players (2018-2023)
   Table 97. Breakdown of Embolotherapy by Company Type (Tier 1, Tier 2, and Tier 3)
   Table 98. Market Position of Players in Embolotherapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
   Table 99. Head Office of Key Embolotherapy Players
   Table 100. Embolotherapy Market: Company Product Type Footprint
   Table 101. Embolotherapy Market: Company Product Application Footprint
   Table 102. Embolotherapy New Market Entrants and Barriers to Market Entry
   Table 103. Embolotherapy Mergers, Acquisition, Agreements, and Collaborations
   Table 104. Global Embolotherapy Consumption Value (USD Million) by Type (2018-2023)
   Table 105. Global Embolotherapy Consumption Value Share by Type (2018-2023)
   Table 106. Global Embolotherapy Consumption Value Forecast by Type (2024-2029)
   Table 107. Global Embolotherapy Consumption Value by Application (2018-2023)
   Table 108. Global Embolotherapy Consumption Value Forecast by Application (2024-2029)
   Table 109. North America Embolotherapy Consumption Value by Type (2018-2023) & (USD Million)
   Table 110. North America Embolotherapy Consumption Value by Type (2024-2029) & (USD Million)
   Table 111. North America Embolotherapy Consumption Value by Application (2018-2023) & (USD Million)
   Table 112. North America Embolotherapy Consumption Value by Application (2024-2029) & (USD Million)
   Table 113. North America Embolotherapy Consumption Value by Country (2018-2023) & (USD Million)
   Table 114. North America Embolotherapy Consumption Value by Country (2024-2029) & (USD Million)
   Table 115. Europe Embolotherapy Consumption Value by Type (2018-2023) & (USD Million)
   Table 116. Europe Embolotherapy Consumption Value by Type (2024-2029) & (USD Million)
   Table 117. Europe Embolotherapy Consumption Value by Application (2018-2023) & (USD Million)
   Table 118. Europe Embolotherapy Consumption Value by Application (2024-2029) & (USD Million)
   Table 119. Europe Embolotherapy Consumption Value by Country (2018-2023) & (USD Million)
   Table 120. Europe Embolotherapy Consumption Value by Country (2024-2029) & (USD Million)
   Table 121. Asia-Pacific Embolotherapy Consumption Value by Type (2018-2023) & (USD Million)
   Table 122. Asia-Pacific Embolotherapy Consumption Value by Type (2024-2029) & (USD Million)
   Table 123. Asia-Pacific Embolotherapy Consumption Value by Application (2018-2023) & (USD Million)
   Table 124. Asia-Pacific Embolotherapy Consumption Value by Application (2024-2029) & (USD Million)
   Table 125. Asia-Pacific Embolotherapy Consumption Value by Region (2018-2023) & (USD Million)
   Table 126. Asia-Pacific Embolotherapy Consumption Value by Region (2024-2029) & (USD Million)
   Table 127. South America Embolotherapy Consumption Value by Type (2018-2023) & (USD Million)
   Table 128. South America Embolotherapy Consumption Value by Type (2024-2029) & (USD Million)
   Table 129. South America Embolotherapy Consumption Value by Application (2018-2023) & (USD Million)
   Table 130. South America Embolotherapy Consumption Value by Application (2024-2029) & (USD Million)
   Table 131. South America Embolotherapy Consumption Value by Country (2018-2023) & (USD Million)
   Table 132. South America Embolotherapy Consumption Value by Country (2024-2029) & (USD Million)
   Table 133. Middle East & Africa Embolotherapy Consumption Value by Type (2018-2023) & (USD Million)
   Table 134. Middle East & Africa Embolotherapy Consumption Value by Type (2024-2029) & (USD Million)
   Table 135. Middle East & Africa Embolotherapy Consumption Value by Application (2018-2023) & (USD Million)
   Table 136. Middle East & Africa Embolotherapy Consumption Value by Application (2024-2029) & (USD Million)
   Table 137. Middle East & Africa Embolotherapy Consumption Value by Country (2018-2023) & (USD Million)
   Table 138. Middle East & Africa Embolotherapy Consumption Value by Country (2024-2029) & (USD Million)
   Table 139. Embolotherapy Raw Material
   Table 140. Key Suppliers of Embolotherapy Raw Materials

List of Figures

   Figure 1. Embolotherapy Picture
   Figure 2. Global Embolotherapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Embolotherapy Consumption Value Market Share by Type in 2022
   Figure 4. Microspheres for Embolization
   Figure 5. Embolism Particles
   Figure 6. Embolic coils
   Figure 7. Liquid Embolic Agent
   Figure 8. Auxiliary Embolization Material
   Figure 9. Others
   Figure 10. Global Embolotherapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 11. Embolotherapy Consumption Value Market Share by Application in 2022
   Figure 12. Cancer Picture
   Figure 13. Peripheral Aascular Disease Picture
   Figure 14. Nerve System Disease Picture
   Figure 15. Others Picture
   Figure 16. Global Embolotherapy Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 17. Global Embolotherapy Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 18. Global Market Embolotherapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
   Figure 19. Global Embolotherapy Consumption Value Market Share by Region (2018-2029)
   Figure 20. Global Embolotherapy Consumption Value Market Share by Region in 2022
   Figure 21. North America Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 22. Europe Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 23. Asia-Pacific Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 24. South America Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 25. Middle East and Africa Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 26. Global Embolotherapy Revenue Share by Players in 2022
   Figure 27. Embolotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
   Figure 28. Global Top 3 Players Embolotherapy Market Share in 2022
   Figure 29. Global Top 6 Players Embolotherapy Market Share in 2022
   Figure 30. Global Embolotherapy Consumption Value Share by Type (2018-2023)
   Figure 31. Global Embolotherapy Market Share Forecast by Type (2024-2029)
   Figure 32. Global Embolotherapy Consumption Value Share by Application (2018-2023)
   Figure 33. Global Embolotherapy Market Share Forecast by Application (2024-2029)
   Figure 34. North America Embolotherapy Consumption Value Market Share by Type (2018-2029)
   Figure 35. North America Embolotherapy Consumption Value Market Share by Application (2018-2029)
   Figure 36. North America Embolotherapy Consumption Value Market Share by Country (2018-2029)
   Figure 37. United States Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 38. Canada Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 39. Mexico Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 40. Europe Embolotherapy Consumption Value Market Share by Type (2018-2029)
   Figure 41. Europe Embolotherapy Consumption Value Market Share by Application (2018-2029)
   Figure 42. Europe Embolotherapy Consumption Value Market Share by Country (2018-2029)
   Figure 43. Germany Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 44. France Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 45. United Kingdom Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 46. Russia Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 47. Italy Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 48. Asia-Pacific Embolotherapy Consumption Value Market Share by Type (2018-2029)
   Figure 49. Asia-Pacific Embolotherapy Consumption Value Market Share by Application (2018-2029)
   Figure 50. Asia-Pacific Embolotherapy Consumption Value Market Share by Region (2018-2029)
   Figure 51. China Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 52. Japan Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 53. South Korea Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 54. India Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 55. Southeast Asia Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 56. Australia Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 57. South America Embolotherapy Consumption Value Market Share by Type (2018-2029)
   Figure 58. South America Embolotherapy Consumption Value Market Share by Application (2018-2029)
   Figure 59. South America Embolotherapy Consumption Value Market Share by Country (2018-2029)
   Figure 60. Brazil Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 61. Argentina Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 62. Middle East and Africa Embolotherapy Consumption Value Market Share by Type (2018-2029)
   Figure 63. Middle East and Africa Embolotherapy Consumption Value Market Share by Application (2018-2029)
   Figure 64. Middle East and Africa Embolotherapy Consumption Value Market Share by Country (2018-2029)
   Figure 65. Turkey Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 66. Saudi Arabia Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 67. UAE Embolotherapy Consumption Value (2018-2029) & (USD Million)
   Figure 68. Embolotherapy Market Drivers
   Figure 69. Embolotherapy Market Restraints
   Figure 70. Embolotherapy Market Trends
   Figure 71. Porters Five Forces Analysis
   Figure 72. Manufacturing Cost Structure Analysis of Embolotherapy in 2022
   Figure 73. Manufacturing Process Analysis of Embolotherapy
   Figure 74. Embolotherapy Industrial Chain
   Figure 75. Methodology
   Figure 76. Research Process and Data Source